Trial · NCT00554229
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival | ZD4054 | 24.5 | Full Range 0.5 to 31.2 | months | |
| Overall Survival | Placebo | 22.5 | Full Range 0.5 to 29.8 | months | |
| Progression Free Survival | ZD4054 | 6.2 | Inter-Quartile Range 2.8 to 13.8 | Months | |
| Progression Free Survival | Placebo | 6.5 | Inter-Quartile Range 2.8 to 13.2 | Months | |
| Time to Use of Opiates | ZD4054 | 16.7 | Inter-Quartile Range 7.3 to 27.0 | Months | |
| Time to Use of Opiates | Placebo | 14.8 | Inter-Quartile Range 7.9 to 25.8 | Months | |
| Incidence of Skeletal Related Events | ZD4054 | 18.4 | Inter-Quartile Range 9.6 to 30.6 | Months | |
| Incidence of Skeletal Related Events | Placebo | 17.1 | Inter-Quartile Range 9.3 to 25.8 | Months | |
| Bone Metastases Formation | ZD4054 | 15.1 | Inter-Quartile Range 7.2 to 25.5 | Months | |
| Bone Metastases Formation | Placebo | 11.9 | Inter-Quartile Range 7.0 to 22.5 | Months | |
| Health Related Quality of Life | ZD4054 | 5.5 | Inter-Quartile Range 2.8 to 9.1 | Months | |
| Health Related Quality of Life | Placebo | 5.5 | Inter-Quartile Range 2.8 to 9.1 | Months | |
| Time to Prostate-specific Antigen (PSA) Progression | ZD4054 | 5.6 | Inter-Quartile Range 2.9 to 11.1 | Months | |
| Time to Prostate-specific Antigen (PSA) Progression | Placebo | 5.6 | Inter-Quartile Range 2.8 to 11.4 | Months | |
| Time to Pain Progression | ZD4054 | 9.0 | Inter-Quartile Range 3.3 to 19.4 | Months | |
| Time to Pain Progression | Placebo | 8.4 | Inter-Quartile Range 3.4 to 19.1 | Months | |
| Time to Initiation of Chemotherapy | ZD4054 | 11.4 | Inter-Quartile Range 5.8 to 18.5 | Months | |
| Time to Initiation of Chemotherapy | Placebo | 10.6 | Inter-Quartile Range 6.0 to 18.2 | Months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00554229/results